Interferon-alpha (IFN-alpha) stimulates anti-melanoma cytotoxic T lymphocyte (CTL) generation in mixed lymphocyte tumour cultures (MLTC) (Q73486158)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10691911%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Interferon-alpha (IFN-alpha) stimulates anti-melanoma cytotoxic T lymphocyte (CTL) generation in mixed lymphocyte tumour cultures (MLTC) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10691911%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

K J Palmer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10691911%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Harries

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10691911%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M E Gore

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10691911%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M K Collins

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10691911%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10691911%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10691911%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10691911%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10691911%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

412-418

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10691911%20AND%20SRC:MED&resulttype=core&format=json

Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast

4 November 2019

cites work

1 reference

12 December 2020

Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons

1 reference

12 December 2020

Regulation of MHC expression in vivo. II. IFN-alpha/beta inducers and recombinant IFN-alpha modulate MHC antigen expression in mouse tissues

1 reference

12 December 2020

Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells

1 reference

12 December 2020

Class I major histocompatibility complex enhancement by recombinant leukocyte interferon in the peripheral blood mononuclear cells and plasma of melanoma patients

1 reference

12 December 2020

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

1 reference

12 December 2020

Differential regulation of HLA-A3 and HLA-B7 MHC class I genes by IFN is due to two nucleotide differences in their IFN response sequences.

1 reference

12 December 2020

Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells

1 reference

12 December 2020

Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferon

1 reference

12 December 2020

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

1 reference

12 December 2020

IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells.

1 reference

12 December 2020

Biological response modifiers in melanoma

1 reference

12 December 2020

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

12 December 2020

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

1 reference

12 December 2020

IL-12 stimulation but not B7 expression increases melanoma killing by patient cytotoxic T lymphocytes (CTL)

1 reference

12 December 2020

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

1 reference

12 December 2020

Effect of interferon-alpha on the expression of tumour necrosis factor-alpha by metastatic malignant melanoma in vivo

1 reference

12 December 2020

Tumor antigens recognized by T cells

1 reference

12 December 2020

Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha

1 reference

12 December 2020

The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles

1 reference

12 December 2020

Interferon-alpha-induced activation of signal transducer and activator of transcription proteins in malignant melanoma

1 reference

12 December 2020

Nonviral interferon alpha gene therapy inhibits growth of established tumors by eliciting a systemic immune response

1 reference

12 December 2020

The induction of in vivo proliferation of long-lived CD44hi CD8+ T cells after the injection of tumor cells expressing IFN-alpha1 into syngeneic mice.

1 reference

12 December 2020

IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy.

1 reference

12 December 2020

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

1 reference

12 December 2020

Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma

1 reference

12 December 2020

Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids

1 reference

12 December 2020

IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses.

1 reference

12 December 2020

10.1046/J.1365-2249.2000.01159.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10691911%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

0 references

1 reference